Mirae Asset Global ETFs Holdings’s Armata Pharmaceuticals ARMP Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.4K	Buy	+5,461	New	+$50.1K	﹤0.01%	3081

Other funds holding ARMP

MAM

Madison Asset Management Madison, Wisconsin $8.39B AUM 16.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DIG

Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ARMP Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Armata Pharmaceuticals (ARMP) in Q2 2026: 5,461 shares worth $35.4K. The stake represents ﹤0.01% of the portfolio and ranks #3081 among its holdings.

53 funds tracked by Wall St. Rank hold ARMP as of Q2 2026.

Mirae Asset Global ETFs Holdings held 5,461 shares of Armata Pharmaceuticals worth $35.4K as of Q2 2026.
Armata Pharmaceuticals was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
Armata Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #3081 holding.
53 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.